Skip to the page

Data / Form D filings / biospatial, Inc.

biospatial, Inc.: Form D filings

biospatial, Inc., a technology company in Durham, NC, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on February 22, 2024, reports $709,962 sold of a $709,962 offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4819 EMPEROR BOULEVARD, SUITE 400, Durham, NC, 27703
Phone
(919) 370-6321
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1739765

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 22, 2024New notice$709,962$709,96216Feb 9, 2024sec.gov
May 26, 2022New notice$3,408,733$3,408,73326Mar 21, 2022sec.gov
Oct 27, 2020New notice$1,804,966$1,804,96625Mar 26, 2020sec.gov
Apr 17, 2019New notice$500,000$500,0003Mar 7, 2019sec.gov
Jun 18, 2018New notice$1,114,780$1,114,7807Apr 24, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David GardnerDirector
Jonathan WoodworthExecutive Officer, Director
Paul RunkleDirector
Joshua WaltersExecutive Officer
David JonesDirector

Other technology companies in North Carolina that filed recently

Every Form D from the week of Feb 19, 2024 · All recent filings in North Carolina · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what biospatial, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.